For immediate release 16 August 2006 BioProgress announces enabling technology update Cambridge, UK, 16 August 2006: BioProgress plc ('BioProgress' or the 'Company') (AIM: BPRG; NASDAQ: BPRG), the ...

For immediate release 20 June 2006 BioProgress to acquire Segix Farma S.R.L. Cambridge, UK, 20 June 2006 - The Board of BioProgress plc ("BioProgress" or the "Company") (AIM: BPRG; NASDAQ: BPRG), the ...

Bioprogress is finally living up to its name. But the shares are up 42 per cent since we rated them good value at the time of the interims in October so, on a forward PE ratio of 25, it's all in the ...

OraDisc(TM) B is a product developed from our adhesive film technology which incorporates 15 milligrams of benzocaine for the treatment of oral pain. The product is designed to adhere to the mucosal ...

BioProgress plc and Magenta Oral Dose Design, a business unit of FMC Corporation, have finalized restructuring agreements regarding the licensing of NRobe technology. BioProgress plc and Magenta Oral ...

The expression "a bitter pill to swallow" could soon become obsolete if patients warm to a new type of medicine - a postage-stamp sized film that dissolves on your tongue. Graham Hind, the chief ...

LONDON, Oct 26 (Reuters) - British pharmaceutical and medical devices company BioProgress Plc said it was in advanced talks to acquire U.S. assets and was also considering a cash placing. The group, ...

BioProgress is also developing a range of tablet coatings to replace traditional gelatine coatings. Using a proprietary film, these coatings allow for looser packing, meaning the active compound is ...